IMPLANT FOR TREATING STRESS URINARY INCONTINENCE AND ANTERIOR VAGINAL WALL PROLAPSE

(19)

(11)

EP 1 957 008 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	22.08.2012 Bulletin 2012/34

(45)	Mention of the grant of the patent:
	11.07.2012 Bulletin 2012/28

(21)	Application number: 05850788.0

(22)	Date of filing: 09.12.2005

(51)

International Patent Classification (IPC):

A61F 2/08^(2006.01)

A61F 2/00^(2006.01)

(86)	International application number:
	PCT/IB2005/004089

(87)	International publication number:
	WO 2007/066169 (14.06.2007 Gazette 2007/24)

(54)	IMPLANT FOR TREATING STRESS URINARY INCONTINENCE AND ANTERIOR VAGINAL WALL PROLAPSE IMPLANTAT ZUR BEHANDLUNG VON STRESSINKONTINENZ UND PROLAPS DER VORDEREN VAGINALWAND IMPLANT POUR TRAITER L'INCONTINENCE URINAIRE DE STRESS ET LE PROLAPSUS DE LA PAROI VAGINALE ANTÉRIEURE

(84)	Designated Contracting States:
	DE FR

(43)	Date of publication of application:
	20.08.2008 Bulletin 2008/34

(73)	Proprietor: Promedon SA
	Córdoba (AR)

(72)	Inventor:
	GRIGUOL, Osvaldo, Nicolas Cordora (AR)

(74)	Representative: Dossmann, Gérard
	Casalonga & Partners Bayerstrasse 71-73 80335 München 80335 München (DE)

(56)

References cited: :

WO-A-2004/012626
US-A1- 2003 220 538

WO-A-2004/091442
US-A1- 2004 039 453

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).